HAILEY HOFFMAN: Open Payments
NPI 1548833882 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 6 payments from 6 companies in 2025. Trend: 2023 $204 · 2024 $188 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $118 |
| Biocon Biologics Inc | 1 | $43 |
| Astellas Pharma US Inc | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: JEMPERLI, Ogivri, Veozah, LYNPARZA, AKYNZEO, VRAYLAR.
Industry payments across NV — which companies pay providers there.
